Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Michetti

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2002
Transepithelial transport of HIV-1 by M cells is receptor-mediatedGrigorios Fotopoulos, Alexandre Harari, Pierre Michetti, et al.
Revue Medicale De La Suisse Romande|November 9, 2002
[Detection and prevention of colorectal cancer]Hayssam Moubayed, Razvan Popescu, Steve Aellen, et al.
Scandinavian Journal of Gastroenterology|February 20, 2016
Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?Carla Vaucher, Michel H Maillard, Florian Froehlich, et al.
Plos One|February 11, 2017
Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicatorValérie Pittet, Carla Vaucher, Florian Froehlich, et al.
Current Research in Pharmacology and Drug Discovery|May 16, 2022
Positioning biologics in the treatment of IBD: A practical guide <i>- Which mechanism of action for whom?</i>Pascal Juillerat, Maude Martinho Grueber, Roseline Ruetsch, et al.
Revue Medicale De La Suisse Romande|November 9, 2002
[Colorectal cancer: curative treatment and surveillance]Jean-Claude Givel, Steve Aellen, Hayssam Moubayed, et al.
Revue Medicale Suisse|March 14, 2008
[Main therapeutic advances in IBD in 2007]Christian Felley, Christian Mottet, Michel H Maillard, et al.
European Journal of Gastroenterology & Hepatology|March 10, 2005
Tegaserod is safe, well tolerated and effective in the treatment of patients with non-diarrhoea irritable bowel syndromeMichael Fried, Christoph Beglinger, Nicole Gilgen Bobalj, et al.
Digestion|August 3, 2020
TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User's Guide: An UpdateMarianne Vulliemoz, Stephan Brand, Pascal Juillerat, et al.
Revue Medicale Suisse|March 16, 2007
[Intestinal inflammatory diseases]Christian Felley, Christian Mottet, Jurg Hess, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2002
Transepithelial transport of HIV-1 by M cells is receptor-mediatedGrigorios Fotopoulos, Alexandre Harari, Pierre Michetti, et al.
Revue Medicale De La Suisse Romande|November 9, 2002
[Detection and prevention of colorectal cancer]Hayssam Moubayed, Razvan Popescu, Steve Aellen, et al.
Scandinavian Journal of Gastroenterology|February 20, 2016
Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?Carla Vaucher, Michel H Maillard, Florian Froehlich, et al.
Plos One|February 11, 2017
Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicatorValérie Pittet, Carla Vaucher, Florian Froehlich, et al.
Current Research in Pharmacology and Drug Discovery|May 16, 2022
Positioning biologics in the treatment of IBD: A practical guide <i>- Which mechanism of action for whom?</i>Pascal Juillerat, Maude Martinho Grueber, Roseline Ruetsch, et al.
Revue Medicale De La Suisse Romande|November 9, 2002
[Colorectal cancer: curative treatment and surveillance]Jean-Claude Givel, Steve Aellen, Hayssam Moubayed, et al.
Revue Medicale Suisse|March 14, 2008
[Main therapeutic advances in IBD in 2007]Christian Felley, Christian Mottet, Michel H Maillard, et al.
European Journal of Gastroenterology & Hepatology|March 10, 2005
Tegaserod is safe, well tolerated and effective in the treatment of patients with non-diarrhoea irritable bowel syndromeMichael Fried, Christoph Beglinger, Nicole Gilgen Bobalj, et al.
Digestion|August 3, 2020
TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User's Guide: An UpdateMarianne Vulliemoz, Stephan Brand, Pascal Juillerat, et al.
Revue Medicale Suisse|March 16, 2007
[Intestinal inflammatory diseases]Christian Felley, Christian Mottet, Jurg Hess, et al.
Pageof 15